Radical Prostatectomy

In this episode, Dr. Brandon and Dr. Morgentaler talk about navigating sexual differences in relationships, the latest evidence supporting testosterone therapy after prostate cancer treatment, and practical ways couples can rebuild intimacy and sexual confidence during recovery. 00:00 –...

Another one under the belt for Dr. Bhasin! https://edhub.ama-assn.org/jn-learning/audio-player/19061825 Interview with Shalender Bhasin, MBBS, author of Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial, and Peter C. Albertsen, MD, author...

Abstract Introduction Testosterone deficiency (TD) may occur after radical prostatectomy (RP). Guidance on prevalence, mechanisms, and testosterone-replacement therapy (TRT) safety remains limited. Objective To summarize contemporary evidence on the etiology of post-RP TD. Methods A...

True powerhouse here! In this lecture from the 7th International Prostate Cancer Symposium, Dr. Arthur L. Burnett II presents an in depth exploration of real time intraoperative neuromonitoring during radical prostatectomy. Dr. Burnett discusses how functional nerve mapping and...

Prostate and Erection Anatomy Cavernous Nerve Anatomic Distribution In this video, Dr. Jonathan Clavell, urologist and penile implant expert in Houston, Texas explains everything a man who has undergone prostate cancer surgery (Radical prostatectomy) needs to know for his erectile...

* TD develops in 20-30% of men within 2-4 weeks of RP, with more profound TT suppression among those with higher-grade disease (e.g., Gleason 4+3). Mechanisms include retrograde venous shunting, DVC-induced intratesticular venous pressure elevation, and pneumoperitoneum-induced testicular...

Recovery of sexual function after prostate cancer surgery is a major concern for many patients. In this video from the ISSM and Movember, Dr. Gerald Brock interviews Dr. Andrea Salonia about assessing pre-operative erectile function, what happens in the months following surgery, and the...

https://academic.oup.com/jsm/article/21/Supplement_6/qdae161.019/7916940?login=false&utm_source=etoc&utm_campaign=jsm&utm_medium=email Abstract Introduction Trimix intracavernosal injections (ICI) is believed to be a reliable treatment option for men who underwent radical prostatectomy...

2:43-19:29 Highlights from the ISSM Webinar: Advancing Sexual Medicine Introduction:This ISSM webinar brought together leading experts to discuss cutting-edge topics in sexual medicine, including advancements in penile rehabilitation, testosterone therapy, and approaches to sexual...

In this insightful episode, Dr. Geo welcomes Dr. James Eastham, a renowned urologist from Memorial Sloan Kettering Cancer Center. They discuss the ideal candidates for prostate removal (prostatectomy), the latest surgical approaches, and Dr. Eastham’s experiences and philosophy as a surgeon. Dr...

In this episode of the Dr. Geo podcast, Dr. Geo interviews Dr. Herbert Lepor, the chairman of NYU’s Department of Urology. They discuss Dr. Lepor’s career, his dedication to his patients, and his focus on his role as a father. They also delve into the history of nerve-sparing prostate cancer...

Aditya Bagrodia, MD, FACS, Associate Professor of Urology and Genitourinary Oncology Team Lead at the University of California, San Diego, presents the cons of using PDE5 inhibitors and early penile rehabilitation to treat erectile dysfunction post-radical prostatectomy.

T. Mike Hsieh, MD, MBA, argues in favor of PDE5 inhibitors and early penile rehabilitation in treating erectile dysfunction post-radical prostatectomy.

An update on the current status and future prospects of erectile dysfunction following radical prostatectomy (2022) Heba Asker PhD | Didem Yilmaz‐Oral PhD | Cetin Volkan Oztekin MD | Serap Gur PhD Abstract Background: Radical prostatectomy (RP) and radiation treatment are standard options...

Testosterone (T) Challenge in Men Post-Radical Prostatectomy (RP) with Profoundly Low Testosterone (2022) JFlores Martinez, JPMulhall, SDeveci, KMatsushita, JTorremade, CASalter Introduction Prostate-specific antigen is the primary marker of prostate cancer recurrence. PSA secretion is T...

Abstract Despite the neuroanatomy knowledge of the prostate described initially in the 1980s and the robotic surgery advantages in terms of operative view magnification, potency outcomes following robotic-assisted radical prostatectomy still challenge surgeons and patients due to its...

https://www.urologytimes.com/view/impact-of-raising-testosterone-levels-in-men-after-radical-prostatectomy A “testosterone challenge” approach appears to allow for early detection of prostate cancer recurrence in men with low testosterone after radical prostatectomy (RP), according to a study...